Eric Wiseman - Cigna Corp Lead Independent Director
| CI Stock | USD 337.80 1.30 0.39% |
Director
Mr. Eric C. Wiseman is an Independent Director of the Company. He has served as Executive Chairman of VF Corporationrationration, a publicly traded apparel and footwear company, since August 2008 and has served on its board since 2006. He served as Chief Executive Officer from January 2008 until December 2016 and President from 2006 until June 2015. He served as Chief Operating Officer of VF Corporation from 2006 to 2008 Executive Vice President, Global Brands from 2005 to 2006 Vice President and Chairman, Sportswear and Outdoor Coalitions from 2004 until 2005 and Vice President and Chairman, Global Intimates and Sportswear Coalition from 2003 until 2004. Mr. Wiseman received his BS degree and MBA from Wake Forest University. Mr. Wiseman has extensive senior leadership experience through his positions with VF Corporationrationration. As Chairman and CEO of VF Corporationrationration, he has had oversight of financial operations, merger and acquisition activities and corporate restructurings. Through leadership positions at VF Corporationrationration, Mr. Wiseman oversaw operations and product sales in over 150 countries. Prior to joining VF Corporationrationration, he held executive leadership roles at Sara Lee Corporation that included international business leadership and international assignments. Through leadership roles at VF Corporationrationration, Mr. Wiseman oversaw marketing of a variety of brands through all channels of distribution, both domestically and internationally. As a director of Lowes, a retail home improvement and appliances company, he focuses on enduser consumerrelated issues. since 2022.
| Age | 65 |
| Tenure | 2 years |
| Professional Marks | MBA |
| Address | 900 Cottage Grove Road, Bloomfield, CT, United States, 06002 |
| Phone | 860 226 6000 |
| Web | https://www.cigna.com |
Eric Wiseman Latest Insider Activity
Tracking and analyzing the buying and selling activities of Eric Wiseman against Cigna Corp stock is an integral part of due diligence when investing in Cigna Corp. Eric Wiseman insider activity provides valuable insight into whether Cigna Corp is net buyers or sellers over its current business cycle. Note, Cigna Corp insiders must abide by specific rules, including filing SEC forms every time they buy or sell Cigna Corp'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Eric Wiseman over six months ago Acquisition by Eric Wiseman of 114 shares of Cigna Corp subject to Rule 16b-3 | ||
Eric Wiseman over a year ago Acquisition by Eric Wiseman of 138 shares of Lowes Companies subject to Rule 16b-3 |
Cigna Corp Management Efficiency
The company has Return on Asset (ROA) of 0.028 % which means that for every $100 of assets, it generated a profit of $0.028. This is way below average. Likewise, it shows a return on total equity (ROE) of 0.0761 %, which means that it produced $0.0761 on every 100 dollars invested by current stockholders. Cigna Corp's management efficiency ratios could be used to measure how well Cigna Corp manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Cigna Corp's Return On Tangible Assets are increasing as compared to previous years. The Cigna Corp's current Return On Capital Employed is estimated to increase to 0.09, while Return On Equity is projected to decrease to 0.10. As of now, Cigna Corp's Intangible Assets are increasing as compared to previous years. The Cigna Corp's current Return On Tangible Assets is estimated to increase to 0.07, while Total Assets are projected to decrease to under 89.1 B.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| David Feinberg | Humana Inc | 58 | |
| James OBrien | Humana Inc | 66 | |
| Frank Bisignano | Humana Inc | 62 | |
| JeanPierre Millon | CVS Health Corp | 70 | |
| Tony White | CVS Health Corp | 73 | |
| Timothy Flynn | UnitedHealth Group Incorporated | 64 | |
| Karen Katz | Humana Inc | 64 | |
| Gail Wilensky | UnitedHealth Group Incorporated | 76 | |
| John Noseworthy | UnitedHealth Group Incorporated | 69 | |
| William Weldon | CVS Health Corp | 72 | |
| Glenn Renwick | UnitedHealth Group Incorporated | 64 | |
| Dale Wolf | Molina Healthcare | 66 | |
| Edward Ludwig | CVS Health Corp | 69 | |
| Daniel Cooperman | Molina Healthcare | 70 | |
| Richard Schapiro | Molina Healthcare | 65 | |
| Roger Farah | CVS Health Corp | 71 | |
| NancyAnn DeParle | CVS Health Corp | 64 | |
| William Ballard | UnitedHealth Group Incorporated | 77 | |
| Michele Hooper | UnitedHealth Group Incorporated | 68 | |
| Valerie Rice | UnitedHealth Group Incorporated | 58 | |
| Anne Finucane | CVS Health Corp | 68 | |
Management Performance
| Return On Equity | 0.0761 | ||||
| Return On Asset | 0.028 |
Cigna Corp Leadership Team
Elected by the shareholders, the Cigna Corp's board of directors comprises two types of representatives: Cigna Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cigna. The board's role is to monitor Cigna Corp's management team and ensure that shareholders' interests are well served. Cigna Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cigna Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Arjan Toor, Chief Operations | ||
| Nicole Jones, Executive Vice President, General Counsel | ||
| Matthew Manders, President of U.S. Commercial Markets and Global Health Care Operations | ||
| Donna Zarcone, Independent Director | ||
| Noelle Eder, Executive Vice President, Global Chief Information Officer | ||
| Eric Palmer, Chief Financial Officer, Executive Vice President | ||
| Dean Mirabella, President Markets | ||
| John Webb, President - Health Care | ||
| Cynthia Ryan, Chief Human Resource Officer | ||
| Alexis Jones, Investor Principal | ||
| Mark Boxer, Executive Vice President, Chief Information Officer | ||
| Neesha Hathi, Independent Director | ||
| Nicole JD, Chief VP | ||
| Adam PharmD, President Services | ||
| Jason Sadler, President of International Markets | ||
| Eric Foss, Independent Director | ||
| Timothy Wentworth, Chief Executive Officer - Evernorth | ||
| Isaiah Harris, Independent Chairman of the Board | ||
| John Murabito, Executive Vice President - Human Resources, Chief Administrative Officer | ||
| Christopher MBA, President Businesses | ||
| Roman Martinez, Independent Director | ||
| William DeLaney, Independent Director | ||
| Kristen Lauria, Executive Vice President, Chief Marketing Officer | ||
| Everett Neville, Executive Vice President, Strategy, Corporate Development and Solutions | ||
| Ralph Giacobbe, Senior Relations | ||
| Phil Austin, Head Markets | ||
| Paul Sanford, Executive Vice President - Operations | ||
| John Partridge, Independent Director | ||
| Jamie Kates, Chief Officer | ||
| Mark McClellan, Independent Director | ||
| Kathleen Mazzarella, Independent Director | ||
| Mary CPA, Senior Officer | ||
| MICHAEL TRIPLETT, President - U.S. Commercial | ||
| Steven Miller, Executive Vice President Chief Clinical Officer | ||
| Elder Granger, Independent Director | ||
| Kimberly Ross, Independent Director | ||
| Mary Picerno, Chief Officer | ||
| Brian CFA, CFO VP | ||
| Eric Wiseman, Lead Independent Director | ||
| Brian Evanko, Chief Financial Officer, Executive Vice President | ||
| Matt Perlberg, Pharmacy President | ||
| Kari Stevens, Chief VP | ||
| David Cordani, CEO and President Director and Member of Executive Committee | ||
| Terese CPA, Senior Officer | ||
| William Roper, Independent Director | ||
| George Kurian, Independent Director | ||
| Charles Berg, President - U.S. Government Business |
Cigna Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cigna Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0761 | ||||
| Return On Asset | 0.028 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 120.87 B | ||||
| Shares Outstanding | 278.15 M | ||||
| Shares Owned By Insiders | 1.59 % | ||||
| Shares Owned By Institutions | 89.54 % | ||||
| Number Of Shares Shorted | 3.58 M | ||||
| Price To Earning | 13.93 X |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cigna Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more detail on how to invest in Cigna Stock please use our How to Invest in Cigna Corp guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cigna Corp. If investors know Cigna will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cigna Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.45) | Dividend Share 5.43 | Earnings Share 10.54 | Revenue Per Share 808.024 | Quarterly Revenue Growth 0.28 |
The market value of Cigna Corp is measured differently than its book value, which is the value of Cigna that is recorded on the company's balance sheet. Investors also form their own opinion of Cigna Corp's value that differs from its market value or its book value, called intrinsic value, which is Cigna Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cigna Corp's market value can be influenced by many factors that don't directly affect Cigna Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cigna Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cigna Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cigna Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.